Hera Fertility

We introduce employer healthcare innovations to the world

What’s the issue?

  • Today, at least 9 million Americans face infertility issues each year.

  • 50% of infertility cases include a male factor.

  • 90% of men who seek help are unable to find the right help due to limited available male fertility programs.

Introducing

What they do

Hera Fertility is a precision health platform that makes it incredibly easy for men to learn about and optimize their fertility health.

  • Over 150 patients have received services from Hera Fertility as part of an initial pilot.

  • Over 125 OBGYNs and family doctors have signed agreements with and have begun recommending Hera Fertility.

  • 6 retail stores are already stocking shelves with Hera Fertility’s products.

How they do it

Hera Fertility enables men to get quality testing and care from the home.

  • Semen analysis kits are shipped to patients homes.

  • Personalized treatment programs and insights are offered pending results, including prescriptions, supplements, and app-based coaching.

  • Hera Fertility offers a subscription-based membership package for $399 / year for quarterly testing and results with additional services billed separately to either the employer, health plan, or patient.

Who they are

  • Founders: Thiv Paramsothy, April Rutter

  • Headquarters: New York, New York

  • Employee Count: 5

  • Investors: Techstars, Capital Factory, Foundry Square, Orrick, The Accelerator Centre, Angels (Founder of PagerDuty)

  • Funding Status: $255K raised to-date; currently raising $1.5M

Who else is out there?

  • Legacy: Backed by FirstMark Capital, Bain Capital Ventures, Y Combinator, TQ Ventures, Section 32, and Tribe Capital

  • Posterity: Backed by FCA Venture Partners, Distributed Ventures, and WVV Capital

  • Bastion: Backed by Werth Ventures, Plug and Play, IHD Ventures, UConn Innovation Fund, and MassChallenge

Hera Fertility considers Modern Fertility and Maven as strong comparables, the former having exited for $225M and the latter valued at $1.3B.

Our thoughts

SUCCESS DRIVERS

  • Market Opportunity: With over 4.5M American males experiencing fertility issues, a number that is expected to continue to grow, there is a large opportunity for Hera Fertility to capture. Expansion into other male health segments (e.g., male hormone health, mental health, sexual health, preventive health) represent additional drivers of growth.

  • Strong Comparables in Women’s Fertility: Female fertility solutions such as Progyny, Carrot Fertility, Modern Fertility, and Kindbody have been incredibly successful among self-funded employers, helping pave the path for male fertility solutions to also gain great traction.

  • Comprehensiveness: With a growing sentiment toward adopting holistic solutions, employers may not only appreciate Hera Fertility’s comprehensive male fertility solution, which spans testing, personalized treatment programs, and a clinical network, but also its potential to integrate with larger, established benefit solutions and platforms lacking male fertility capabilities.

POTENTIAL ISSUES

  • Competitive pressure: There is a growing number of competitors also tackling this large market, and more established fertility or men’s health players may also step into this space.

  • Engagement: Telemedicine based workflows can have lower overall engagement; however, this can be countered through strong member enrollment tactics.

  • Broad clinician support: Broad support from the clinical community is critical to support the credibility of at-home male fertility solutions and motivate uptake.

Your thoughts

Here’s what you thought about last week’s startup, MediCircle:

It was a hit! While some expressed concerns around employers and brokers getting comfortable with the idea, overall readers loved the innovative approach to ensure quality medications don’t go to waste and save employers and patients significant money.